Table 3.
Factors influencing overall survival according to the Cox analysis.
| Variables | HR (95% CI) | P |
|---|---|---|
| AFP (ng/ml) | ||
| <400 | 1.000 | |
| ≥400 | 1.317 (0.772–2.401) | 0.369 |
| BCLC stage | ||
| A | 1.000 | |
| B | 2.097 (0.791–5.558) | 0.137 |
| C | 2.108 (0.865–5.137) | 0.101 |
| Tumor number | ||
| Single | 1.000 | |
| Multiple | 1.385 (0.768-2.498) | 0.279 |
| Growth pattern | ||
| Non-infiltrative | 1.000 | |
| Infiltrative | 1.555 (0.743–3.255) | 0.241 |
| Vascular invasion | ||
| Absent | 1.000 | |
| Present | 1.259 (0.701–2.262) | 0.441 |
| Therapy | ||
| TACE-sorafenib-thermal ablation | 1.000 | |
| TACE-sorafenib | 2.512 (1.348–4.680) | 0.004 |
Multivariate analysis was not performed because only the choice of treatment had a P-value <0.05 in univariable analyses. HBV status and Child-Pugh grades could not be analyzed because of the too small number of patients in some categories.